A novel method for oral delivery of drug compounds to the neonatal SMNΔ7 mouse model of spinal muscular atrophy

Journal of Neuroscience Methods

Volumn 161, Issue 2, 2007, Pages 285-290

  Butchbach, Matthew E R ^a   Edwards, Jonathan D ^a   Schussler, Kristie R ^a   Burghes, Arthur H M ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Drug delivery; Mouse; Neonatal; Oral administration; Spinal cord; Spinal muscular atrophy

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BROXURIDINE; DISTILLED WATER; STAINLESS STEEL; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG TARGETING; MOUSE; NEEDLE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SPINAL MUSCULAR ATROPHY;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; BRAIN; BROMODEOXYURIDINE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MICE; MUSCULAR ATROPHY, SPINAL; ORGAN SPECIFICITY; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 33947497858     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.11.002     Document Type: Article

References (25)

1. Bishop J.B., Witt K.L., Tice R.R., and Wolfe G.W. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3′-azido-3′-deoxythymidine and dideoxyinosine via maternal dosing, nursing and direct gavage. Environ Mol Mutagen 43 (2004) 3-9
2. Brown A.P., Dinger N., and Levine B.S. Stress produced by gavage administration in the rat. Contemp Top Lab Anim Sci 39 (2000) 17-21
3. Butchbach M.E.R., and Burghes A.H.M. Perspectives on models of spinal muscular atrophy for drug discovery. Drug Discov Today Dis Model 1 (2004) 151-156
4. Chang J.G., Hsieh-Li H.M., Jong Y.J., Wang N.M., Tsai C.H., and Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98 (2001) 9808-9813
5. Coovert D.D., Le T.T., McAndrew P.E., Strasswimmer J., Crawford T.O., Mendell J.R., et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6 (1997) 1205-1214
6. Crawford T.O., and Pardo C.A. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3 (1996) 97-110
7. DiDonato C.J., Chen X.N., Noya D., Korenberg J.R., Nadeau J.H., and Simard L.R. Cloning, characterization and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res 7 (1997) 339-352
8. Duysen E.G., Stribley J.A., Fry D.L., Hinrichs S.H., and Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Dev Brain Res 137 (2002) 43-54
9. Hirayama F., and Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev 36 (1999) 125-141
10. Hsieh-Li H.M., Chang J.G., Jong Y.J., Wu M.H., Wang N.M., Tsai C.H., et al. A mouse model for spinal muscular atrophy. Nat Genet 24 (2000) 66-70
11. Le T.T., Pham L.T., Butchbach M.E.R., Zhang H.L., Monani U.R., Coovert D.D., et al. SMNΔ7, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14 (2005) 845-857
12. Lefebvre S., Burlet P., Liu Q., Bertrandy S., Clermont O., Munnich A., et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16 (1997) 265-269
13. Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80 (1995) 155-165
14. C gene copy number. Am J Hum Genet 60 (1997) 1411-1422
15. Monani U.R., Pastore M.T., Gavrilina T.O., Jablonka S., Le T.T., Andreassi C., et al. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol 160 (2003) 41-52
16. Monani U.R., Sendtner M., Coovert D.D., Parsons D.W., Andreassi C., Le T.T., et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9 (2000) 333-339
17. Murphy S.J., Smith P., Shaivitz A.B., Rossberg M.I., and Hurn P.D. The effect of brief halothane anesthesia during daily gavage on complications and body weights in rats. Contemp Top Lab Anim Sci 40 (2001) 9-12
18. Nesfield S.R., Williams T.C., Hoivik D.J., Miller R.T., Allen J.S., Selinger K., et al. Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse. Int J Toxicol 24 (2005) 341-348
19. Parsons D.W., McAndrew P.E., Iannaccone S.T., Mendell J.R., Burghes A.H.M., and Prior T.W. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 63 (1998) 1712-1723
20. Santosa A., Kaiser A., and Winter Y. Individually dosed oral administration to socially living transponder-tagged mice by a water dispenser under RFID control. J Neurosci Methods 153 (2006) 208-213
21. Schleimer S.B., Johnston G.A.R., and Henderson J.M. Novel oral administration in an animal model of neuroleptic therapy. J Neurosci Methods 146 (2005) 159-164
22. Schrank B., Götz R., Gunnersen J.M., Ure J.M., Toyka K.V., Smith A.G., et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 94 (1997) 9920-9925
23. Ueda J., Saito H., Watanabe H., and Evers B.M. Novel and quantitative DNA dot-blotting methods for assessment of in vivo proliferation. Am J Physiol 288 (2005) G842-G847
24. Viollet L., Bertrandy S., Beuno Brunialti A.L., Lefebvre S., Burlet P., Clermont O., et al. cDNA isolation, expression and chromosomal localization of the mouse survival motor neuron gene (Smn). Genomics 40 (1997) 185-188
25. Wheeler TL, Eppolito AK, Smith LN, Huff TB, Smith RF. A novel method for oral stimulant administration in the neonate rat and similar species. J Neurosci Methods, 2006, doi:10.1016/j.neumeth.2006.07.019.